Song‐Bin Guo

748 total citations · 1 hit paper
23 papers, 354 citations indexed

About

Song‐Bin Guo is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Song‐Bin Guo has authored 23 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Pathology and Forensic Medicine and 5 papers in Oncology. Recurrent topics in Song‐Bin Guo's work include Radiomics and Machine Learning in Medical Imaging (4 papers), Colorectal Cancer Surgical Treatments (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). Song‐Bin Guo is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (4 papers), Colorectal Cancer Surgical Treatments (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). Song‐Bin Guo collaborates with scholars based in China, Japan and Poland. Song‐Bin Guo's co-authors include Xiao‐Peng Tian, Weijuan Huang, Hailong Li, Meng Yuan, Jing‐Kai Huang, Shigeo Manabe, Hui Luo, Osamu Wada, Weijuan Huang and Hiroyuki Yanagisawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Industrial & Engineering Chemistry Research and Molecular Cancer.

In The Last Decade

Song‐Bin Guo

21 papers receiving 351 citations

Hit Papers

Artificial intelligence alphafold model for molecular bio... 2024 2026 2025 2024 20 40 60

Peers

Song‐Bin Guo
Sung Lyea Park South Korea
Tong Xu China
Jiacai Wu China
Liuyi Lu China
Xinmei Li China
Yipeng Xu China
Sung Lyea Park South Korea
Song‐Bin Guo
Citations per year, relative to Song‐Bin Guo Song‐Bin Guo (= 1×) peers Sung Lyea Park

Countries citing papers authored by Song‐Bin Guo

Since Specialization
Citations

This map shows the geographic impact of Song‐Bin Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Song‐Bin Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Song‐Bin Guo more than expected).

Fields of papers citing papers by Song‐Bin Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Song‐Bin Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Song‐Bin Guo. The network helps show where Song‐Bin Guo may publish in the future.

Co-authorship network of co-authors of Song‐Bin Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Song‐Bin Guo. A scholar is included among the top collaborators of Song‐Bin Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Song‐Bin Guo. Song‐Bin Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Zhiwei, Jiabin Lu, Song‐Bin Guo, et al.. (2025). A Mitochondria‐Related Signature in Diffuse Large B‐Cell Lymphoma: Prognosis, Immune and Therapeutic Features. Cancer Medicine. 14(2). e70602–e70602. 3 indexed citations
2.
Guo, Song‐Bin, et al.. (2025). Large language model ChatGPT in healthcare scenarios: a global-scale, cross-sectional, machine learning-based informatics study. International Journal of Surgery. 112(3). 8961–8963.
3.
Guo, Song‐Bin, Xiaojie Fang, Yuan Meng, et al.. (2025). Current concerns and future directions of large language model ChatGPT in medicine: a machine-learning-driven global-scale bibliometric analysis. International Journal of Surgery. 112(2). 2805–2822. 1 indexed citations
4.
Zhou, Huiyuan, Jindong Xie, Song‐Bin Guo, et al.. (2025). A novel angiotensin I-converting enzyme (ACE) inhibitory peptide from Wuyi rock tea residue: Preparation, identification, and its potential molecular mechanism. LWT. 216. 117353–117353. 5 indexed citations
5.
Kadier, Kaisaierjiang, Peng Yuan, Yu Yang, et al.. (2025). Mapping heterogeneous molecular subtypes of circadian misalignment underlying lung adenocarcinoma risk. 1(3). e137–e137. 1 indexed citations
6.
Luo, Xin, et al.. (2025). Ordered Mesoporous Silica Encased Palladium Catalyst for Enhancing Activity and Selectivity in Semihydrogenation. Industrial & Engineering Chemistry Research. 64(5). 2665–2673.
7.
Zhang, Shiqian, Ge Zhang, Wenxiu Wang, et al.. (2024). An assessment system for clinical and biological interpretability in ulcerative colitis. Aging. 16(4). 3856–3879. 6 indexed citations
8.
Zhang, Shiqian, Ge Zhang, Song‐Bin Guo, et al.. (2024). Artificial Intelligence Hybrid Survival Assessment System for Robot-Assisted Proctectomy: A Retrospective Cohort Study. JCO Precision Oncology. 8(8). e2400089–e2400089. 6 indexed citations
9.
Guo, Song‐Bin, et al.. (2024). Artificial intelligence alphafold model for molecular biology and drug discovery: a machine-learning-driven informatics investigation. Molecular Cancer. 23(1). 223–223. 60 indexed citations breakdown →
10.
Hu, Rong, Song‐Bin Guo, & Min Liu. (2024). Knowledge map of thrombopoietin receptor agonists: A bibliometric analysis. Heliyon. 10(1). e24051–e24051. 11 indexed citations
11.
Zhou, Huiyuan, Jindong Xie, Song‐Bin Guo, et al.. (2024). Preparation and stability of angiotensin-I-converting enzyme (ACE) inhibitory peptides from protein hydrolysate of Wuyi rock tea residues. CyTA - Journal of Food. 22(1). 1 indexed citations
12.
Tian, Xiao‐Peng, Yi Cao, Jun Cai, et al.. (2023). Novel target and treatment agents for natural killer/T-cell lymphoma. Journal of Hematology & Oncology. 16(1). 78–78. 9 indexed citations
13.
Jiang, Lijuan, et al.. (2023). PHB promotes bladder cancer cell epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway. Pathology - Research and Practice. 247. 154536–154536. 14 indexed citations
14.
Guo, Song‐Bin, et al.. (2023). Comprehensive scientometrics and visualization study profiles lymphoma metabolism and identifies its significant research signatures. Frontiers in Endocrinology. 14. 1266721–1266721. 14 indexed citations
15.
Huang, Weijuan, Song‐Bin Guo, Hui Shi, et al.. (2023). The β-catenin-LINC00183-miR-371b-5p-Smad2/LEF1 axis promotes adult T-cell lymphoblastic lymphoma progression and chemoresistance. Journal of Experimental & Clinical Cancer Research. 42(1). 105–105. 18 indexed citations
17.
Guo, Song‐Bin, et al.. (2020). Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway. Cancer Chemotherapy and Pharmacology. 85(6). 1097–1108. 31 indexed citations
18.
Jiang, Lili, Pei Dong, Zhiyuan Zhang, et al.. (2015). Akt phosphorylates Prohibitin 1 to mediate its mitochondrial localization and promote proliferation of bladder cancer cells. Cell Death and Disease. 6(2). e1660–e1660. 56 indexed citations
19.
Guo, Song‐Bin, Shigeo Manabe, & Osamu Wada. (1989). The decomposition and aggregation of rat lens protein induced by selenite in vitro and in vivo.. Nippon Eiseigaku Zasshi (Japanese Journal of Hygiene). 44(2). 615–621. 2 indexed citations
20.
Manabe, Shigeo, Hiroyuki Yanagisawa, Song‐Bin Guo, et al.. (1987). Detection of Trp-P-1 and Trp-P-2, carcinogenic tryptophan pyrolysis products, in dialysis fluid of patients with uremia. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 179(1). 33–40. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026